What potential role is there for medication treatment in anorexia nervosa?
Authors:
- Scott J. CrowSCScott J. Crow
- James D. RoerigJRJames D. Roerig
- 6 August 2008
- journal article
- review article
- Published by Wiley in International Journal of Eating Disorders
- Vol. 42 (1) , 1-8
Abstract
Objective: To review selected issues regarding the development of drug treatments for anorexia nervosa (AN).Method: The existing pharmacotherapy literature for AN is reviewed, and the theoretical and practical considerations are discussed.Results: A very wide variety of drugs have been examined in AN, generally with negative results. There are a number of potential reasons for this finding, including compliance, nutritional deficits, selection of the wrong targets or the wrong outcome measures, use of monotherapy, lack of animal models, or factors intrinsic to AN.Conclusion: Pharmacotherapy provides little benefit in the treatment of AN at present. Several strategies might lead to the identification of more effective agents, including new measurement strategies, identification of novel pharmacologic targets, and consideration of a clinical trials network. © 2008 by Wiley Periodicals, Inc. Int J Eat Disord 2009Keywords
This publication has 89 references indexed in Scilit:
- New Paradigms for Treatment DevelopmentSchizophrenia Bulletin, 2007
- Anorexia nervosa treatment: A systematic review of randomized controlled trialsInternational Journal of Eating Disorders, 2007
- Quetiapine in anorexia nervosa patients: An open label outpatient pilot studyInternational Journal of Eating Disorders, 2006
- Hippocampal volume and cognitive function in anorexia nervosaPsychiatry Research: Neuroimaging, 2006
- Neurobiology of anorexia nervosa: Clinical implications of alterations of the function of serotonin and other neuronal systemsInternational Journal of Eating Disorders, 2005
- Psychopharmakotherapie mit Clomipramin und Paroxetin bei jugendlichen Patientinnen mit «Anorexia nervosa» und «Depressiver Episode» - eine Pilotstudie zu Verträglichkeit, Absetzquote und therapeutischen VerlaufskriterienZeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 2004
- Investigational drugs for eating disordersExpert Opinion on Investigational Drugs, 2003
- Six‐month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: A preliminary reportInternational Journal of Eating Disorders, 2003
- Intriguing links between animal behavior and anorexia nervosaInternational Journal of Eating Disorders, 1997
- Combined Cognitive-Behavioral, Psychopharmacological and Nutritional Therapy in Eating DisordersNeuropsychobiology, 1995